On June 3, 2026, Aditxt, Inc. and its subsidiary Ignite Proteomics LLC issued senior secured convertible notes with an aggregate original principal amount consisting of approximately $725,000 in cash proceeds plus the consolidation of existing promissory notes totaling $4,444,444.44. The notes include a 35% original issue discount. To secure the notes, Ignite granted a security interest in substantially all its assets, and Aditxt pledged its equity in Ignite. Aditxt operates in the biotechnology industry, focusing on proteomics and diagnostic tools.
